UPC_CoA_405/2024

TREATMENT OF PAROXYSMAL NOCTURNAL HEMOGLOBINURIA PATIENTS BY AN INHIBITOR OF COMPLEMENT

AppealsMain AppealCourt of AppealAppealCase Closed

This case cites

Authorities cited within the decisions on file for this case.

Target	Legal point	Strength	Excerpt
T1515/20	sufficiency — EPO TBA finding on sufficiency of antibody disclosure	Persuasive	This argument was accepted by the TBA, which accordingly concluded that the claimed antibody was sufficiently disclosed in the patent (T 1515/20, par. 35 and 36).

Cited by

Subsequent UPC decisions citing this case.

Cited in	Date	Legal point	Strength	Excerpt
UPC_APP_8339/2025 Court of Appeal	Jun 19, 2025	order under review — dismissal of provisional measures appeal	Background	Order of the Court of Appeal of the Unified Patent Court, 20 December 2024, ORD_60221/2024, APL_40553/2024, UPC_CoA_405/2024